These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23426722)

  • 1. Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.
    MacKinnon AC; Liu X; Hadoke PW; Miller MR; Newby DE; Sethi T
    Glycobiology; 2013 Jun; 23(6):654-63. PubMed ID: 23426722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
    Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J
    Mol Med Rep; 2017 Jul; 16(1):647-653. PubMed ID: 28560429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.
    Chandak PG; Obrowsky S; Radovic B; Doddapattar P; Aflaki E; Kratzer A; Doshi LS; Povoden S; Ahammer H; Hoefler G; Levak-Frank S; Kratky D
    Biochim Biophys Acta; 2011 Dec; 1811(12):1011-20. PubMed ID: 21924378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.
    De Beer MC; Wroblewski JM; Noffsinger VP; Rateri DL; Howatt DA; Balakrishnan A; Ji A; Shridas P; Thompson JC; van der Westhuyzen DR; Tannock LR; Daugherty A; Webb NR; De Beer FC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):255-61. PubMed ID: 24265416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model.
    Williams H; Simmonds S; Bond A; Somos A; Li Z; Forbes T; Bianco R; Dugdale C; Brown Z; Rice H; Herman A; Johnson J; George S
    Atherosclerosis; 2024 Oct; 397():118570. PubMed ID: 39276419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aged Garlic Extract Suppresses the Development of Atherosclerosis in Apolipoprotein E-Knockout Mice.
    Morihara N; Hino A; Yamaguchi T; Suzuki J
    J Nutr; 2016 Feb; 146(2):460S-463S. PubMed ID: 26764329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- mice.
    Olivon VC; Fraga-Silva RA; Segers D; Demougeot C; de Oliveira AM; Savergnini SS; Berthelot A; de Crom R; Krams R; Stergiopulos N; da Silva RF
    Atherosclerosis; 2013 Apr; 227(2):236-43. PubMed ID: 23390893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
    Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
    Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
    Guo X; Wang L; Xia X; Wang P; Li X
    Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.
    Parolini C; Vik R; Busnelli M; Bjørndal B; Holm S; Brattelid T; Manzini S; Ganzetti GS; Dellera F; Halvorsen B; Aukrust P; Sirtori CR; Nordrehaug JE; Skorve J; Berge RK; Chiesa G
    PLoS One; 2014; 9(5):e97598. PubMed ID: 24840793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
    Wu H; Cheng XW; Hu L; Hao CN; Hayashi M; Takeshita K; Hamrah MS; Shi GP; Kuzuya M; Murohara T
    Atherosclerosis; 2014 Dec; 237(2):739-47. PubMed ID: 25463114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
    Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
    Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
    Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
    Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 Identifies a Subset of Macrophages With a Potential Beneficial Role in Atherosclerosis.
    Di Gregoli K; Somerville M; Bianco R; Thomas AC; Frankow A; Newby AC; George SJ; Jackson CL; Johnson JL
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1491-1509. PubMed ID: 32295421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.